Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 15, 2012Generics and Biosimilars Initiative Journal

Saving money in the European healthcare systems with biosimilars

View Full Paper
Ask AI
Bookmark
Share

Authors

RHRobert HausteinIGES Institut

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Robert Haustein (2012) studied this question.

synapsesocial.com/papers/6a830b0f3efdfb27564cd03ehttps://doi.org/10.5639/gabij.2012.0103-4.036
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Do Pharmaceutical Prices Respond to Potential Patient Out-of-Pocket Expenses?2002 · 160 citations
  2. 2Biosimilars and biopharmaceuticals: what the nephrologists need to know--a position paper by the ERA-EDTA Council2008 · 67 citations
  3. 3Biosimilars: Are They Ready for Primetime in the United States?2011 · 33 citations
  4. 4Hematopoietic Stem Cell Transplantation A Global Perspective2010 · 680 citations
  5. 5Biosimilars: How similar or dissimilar are they? (Review Article)2006 · 90 citations